Approvals/TGA/ROPIVACAINE KABI ropivacaine hydrochloride 150 mg/20 mL solution for injection ampoule

Approved

STANDARD

ROPIVACAINE KABI ropivacaine hydrochloride 150 mg/20 mL solution for injection ampoule

Fresenius Kabi Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: ae48f410febd828f
Product Name: ROPIVACAINE KABI ropivacaine hydrochloride 150 mg/20 mL solution for injection ampoule
Artg Id: 195807
Artg Name: ROPIVACAINE KABI ropivacaine hydrochloride 150 mg/20 mL solution for injection ampoule
Sponsor: Fresenius Kabi Australia Pty Ltd
Company Detail Path: /organization/fresenius-kabi-australia-pty-ltd
Artg Date: 2013-06-13
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: RE
Consumer Medicine Info: https://medical-cdn.nocode.com/drug_tga/226c98ae2f0775f06a95d5e34636af70.pdf
Product Information: https://medical-cdn.nocode.com/drug_tga/854bd5b0219721fe85c3cde27104b31e.pdf

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 29, 2025

Approval ID

ae48f410febd828f

Type

Standard